In 2017, the IT industry advanced deeper into the journey of creating a pervasive digital fabric that layers increasing technology enablers across nearly every facet of business. The surprising part is that this new landscape is just in the beginning stages. 2017 will be remembered as the year the Internet of Things (IoT), artificial intelligence (AI) and virtual reality (VR) edged closer to mainstream adoption across industry and society.
Topics: Information Technology
The development of novel enzyme inhibitors has led to effective therapeutic options for diseases that were once considered difficult to treat. A newly updated study by BCC Research finds that approvals of new molecular entities will drive the global market for enzyme inhibitors to $179.9 billion by 2022. Enzyme inhibitors offer therapeutic options for myriad illnesses, including HCV, HIV, cancer, gastrointestinal disease, cardiovascular disease, inflammatory disorders, rheumatoid arthritis, neurological disorders (depression, Parkinson’s disease, Alzheimer’s disease) and diabetes.
What amazed historians about the fall of the USSR, was that it had stayed together so long. The same can be said of Nantero.
The continuous glucose monitoring market, introduced nearly 20 years ago, is presently experiencing strong growth as diabetics, physicians, hospitals and clinics witness the benefits these devices can lend to the management of glucose levels. The market now includes blood glucose monitors, diabetes test strips, insulin durable and patch pumps, glucose sensors, and transmitters and receivers. The global market for continuous glucose monitoring equipment is expected to top $20.6 billion by 2022, according to a new study by BCC Research, at a five-year compound annual growth rate (CAGR) of 10.1%.